| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | extracellular matrix structural constituent conferring tensile strength | 4.16e-07 | 46 | 27 | 4 | GO:0030020 | |
| GeneOntologyMolecularFunction | aryl hydrocarbon receptor binding | 6.30e-05 | 9 | 27 | 2 | GO:0017162 | |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | 1.13e-04 | 188 | 27 | 4 | GO:0005201 | |
| GeneOntologyMolecularFunction | proteasome binding | 3.30e-04 | 20 | 27 | 2 | GO:0070628 | |
| GeneOntologyBiologicalProcess | glomerular basement membrane development | 7.38e-05 | 10 | 27 | 2 | GO:0032836 | |
| GeneOntologyBiologicalProcess | extracellular matrix organization | 1.15e-04 | 377 | 27 | 5 | GO:0030198 | |
| GeneOntologyBiologicalProcess | extracellular structure organization | 1.17e-04 | 378 | 27 | 5 | GO:0043062 | |
| GeneOntologyBiologicalProcess | external encapsulating structure organization | 1.18e-04 | 379 | 27 | 5 | GO:0045229 | |
| GeneOntologyCellularComponent | collagen trimer | 5.56e-06 | 88 | 28 | 4 | GO:0005581 | |
| GeneOntologyCellularComponent | basement membrane | 2.03e-05 | 122 | 28 | 4 | GO:0005604 | |
| GeneOntologyCellularComponent | collagen type IV trimer | 2.59e-05 | 6 | 28 | 2 | GO:0005587 | |
| GeneOntologyCellularComponent | basement membrane collagen trimer | 4.82e-05 | 8 | 28 | 2 | GO:0098651 | |
| GeneOntologyCellularComponent | network-forming collagen trimer | 4.82e-05 | 8 | 28 | 2 | GO:0098642 | |
| GeneOntologyCellularComponent | collagen network | 4.82e-05 | 8 | 28 | 2 | GO:0098645 | |
| GeneOntologyCellularComponent | paraspeckles | 7.73e-05 | 10 | 28 | 2 | GO:0042382 | |
| GeneOntologyCellularComponent | complex of collagen trimers | 3.58e-04 | 21 | 28 | 2 | GO:0098644 | |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | 6.23e-04 | 530 | 28 | 5 | GO:0062023 | |
| GeneOntologyCellularComponent | extracellular matrix | 1.62e-03 | 656 | 28 | 5 | GO:0031012 | |
| GeneOntologyCellularComponent | external encapsulating structure | 1.64e-03 | 658 | 28 | 5 | GO:0030312 | |
| HumanPheno | Glomerular basement membrane lamellation | 8.32e-06 | 3 | 9 | 2 | HP:0030034 | |
| HumanPheno | Thin glomerular basement membrane | 8.32e-06 | 3 | 9 | 2 | HP:0012577 | |
| HumanPheno | Lenticonus | 1.24e-04 | 10 | 9 | 2 | HP:0001142 | |
| HumanPheno | Thickened glomerular basement membrane | 1.81e-04 | 12 | 9 | 2 | HP:0004722 | |
| HumanPheno | Abnormal glomerular basement membrane morphology | 2.14e-04 | 13 | 9 | 2 | HP:0033282 | |
| HumanPheno | Glomerular subepithelial deposits | 2.50e-04 | 14 | 9 | 2 | HP:0033603 | |
| MousePheno | sensorineural hearing impairment | 2.75e-05 | 38 | 22 | 3 | MP:0006329 | |
| MousePheno | podocyte foot process effacement | 2.75e-05 | 38 | 22 | 3 | MP:0008140 | |
| MousePheno | abnormal renal glomerulus basement membrane morphology | 4.30e-05 | 44 | 22 | 3 | MP:0011348 | |
| MousePheno | podocyte hypertrophy | 4.94e-05 | 7 | 22 | 2 | MP:0011871 | |
| MousePheno | abnormal podocyte foot process morphology | 8.42e-05 | 55 | 22 | 3 | MP:0008059 | |
| MousePheno | abnormal podocyte morphology | 1.73e-04 | 70 | 22 | 3 | MP:0005326 | |
| MousePheno | abnormal glomerular capsule visceral layer morphology | 1.73e-04 | 70 | 22 | 3 | MP:0011497 | |
| MousePheno | abnormal neurohypophysis morphology | 3.56e-04 | 18 | 22 | 2 | MP:0004164 | |
| MousePheno | hematuria | 3.98e-04 | 19 | 22 | 2 | MP:0005161 | |
| MousePheno | glomerular crescent | 3.98e-04 | 19 | 22 | 2 | MP:0011506 | |
| Domain | RRM | 4.35e-07 | 217 | 26 | 6 | SM00360 | |
| Domain | RRM_dom | 5.67e-07 | 227 | 26 | 6 | IPR000504 | |
| Domain | RRM | 6.12e-07 | 230 | 26 | 6 | PS50102 | |
| Domain | - | 8.65e-07 | 244 | 26 | 6 | 3.30.70.330 | |
| Domain | Nucleotide-bd_a/b_plait | 1.20e-06 | 258 | 26 | 6 | IPR012677 | |
| Domain | Collagen | 5.53e-06 | 85 | 26 | 4 | PF01391 | |
| Domain | Collagen | 5.53e-06 | 85 | 26 | 4 | IPR008160 | |
| Domain | RRM_1 | 8.88e-06 | 208 | 26 | 5 | PF00076 | |
| Domain | C4 | 2.79e-05 | 6 | 26 | 2 | SM00111 | |
| Domain | - | 2.79e-05 | 6 | 26 | 2 | 2.170.240.10 | |
| Domain | Collagen_VI_NC | 2.79e-05 | 6 | 26 | 2 | IPR001442 | |
| Domain | NC1_IV | 2.79e-05 | 6 | 26 | 2 | PS51403 | |
| Domain | C4 | 2.79e-05 | 6 | 26 | 2 | PF01413 | |
| Domain | PAS | 5.48e-04 | 25 | 26 | 2 | PF00989 | |
| Domain | PAS_fold | 5.48e-04 | 25 | 26 | 2 | IPR013767 | |
| Domain | PAC | 5.93e-04 | 26 | 26 | 2 | SM00086 | |
| Domain | PAC | 5.93e-04 | 26 | 26 | 2 | IPR001610 | |
| Domain | PAS | 9.01e-04 | 32 | 26 | 2 | SM00091 | |
| Domain | PAS | 1.02e-03 | 34 | 26 | 2 | IPR000014 | |
| Domain | PAS | 1.02e-03 | 34 | 26 | 2 | PS50112 | |
| Domain | CTDL_fold | 9.66e-03 | 107 | 26 | 2 | IPR016187 | |
| Domain | - | 1.00e-02 | 109 | 26 | 2 | 4.10.280.10 | |
| Domain | HLH | 1.13e-02 | 116 | 26 | 2 | SM00353 | |
| Domain | BHLH | 1.15e-02 | 117 | 26 | 2 | PS50888 | |
| Domain | bHLH_dom | 1.17e-02 | 118 | 26 | 2 | IPR011598 | |
| Pathway | PID_AVB3_INTEGRIN_PATHWAY | 5.74e-06 | 74 | 23 | 4 | M160 | |
| Pathway | REACTOME_COLLAGEN_CHAIN_TRIMERIZATION | 3.88e-05 | 41 | 23 | 3 | MM15538 | |
| Pathway | REACTOME_COLLAGEN_CHAIN_TRIMERIZATION | 4.81e-05 | 44 | 23 | 3 | M27812 | |
| Pathway | PID_SYNDECAN_1_PATHWAY | 5.50e-05 | 46 | 23 | 3 | M198 | |
| Pathway | WP_MRNA_PROCESSING | 6.59e-05 | 451 | 23 | 6 | MM15946 | |
| Pathway | BIOCARTA_NPP1_PATHWAY | 1.14e-04 | 10 | 23 | 2 | M22040 | |
| Pathway | BIOCARTA_NPP1_PATHWAY | 1.14e-04 | 10 | 23 | 2 | MM1560 | |
| Pathway | REACTOME_ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES | 1.28e-04 | 61 | 23 | 3 | M27103 | |
| Pathway | REACTOME_COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES | 1.28e-04 | 61 | 23 | 3 | MM14637 | |
| Pathway | BIOCARTA_VITCB_PATHWAY | 1.39e-04 | 11 | 23 | 2 | M15422 | |
| Pathway | REACTOME_COLLAGEN_DEGRADATION | 1.48e-04 | 64 | 23 | 3 | M26953 | |
| Pathway | BIOCARTA_VITCB_PATHWAY | 1.66e-04 | 12 | 23 | 2 | MM1526 | |
| Pathway | REACTOME_COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES | 1.70e-04 | 67 | 23 | 3 | M26999 | |
| Pathway | BIOCARTA_ACE2_PATHWAY | 1.96e-04 | 13 | 23 | 2 | MM1347 | |
| Pathway | BIOCARTA_ACE2_PATHWAY | 1.96e-04 | 13 | 23 | 2 | M12950 | |
| Pathway | BIOCARTA_PLATELETAPP_PATHWAY | 2.29e-04 | 14 | 23 | 2 | MM1458 | |
| Pathway | BIOCARTA_PLATELETAPP_PATHWAY | 2.29e-04 | 14 | 23 | 2 | M6487 | |
| Pathway | REACTOME_COLLAGEN_FORMATION | 2.47e-04 | 76 | 23 | 3 | MM14573 | |
| Pathway | REACTOME_LAMININ_INTERACTIONS | 2.64e-04 | 15 | 23 | 2 | MM14922 | |
| Pathway | REACTOME_ANCHORING_FIBRIL_FORMATION | 2.64e-04 | 15 | 23 | 2 | M27161 | |
| Pathway | REACTOME_CROSSLINKING_OF_COLLAGEN_FIBRILS | 3.83e-04 | 18 | 23 | 2 | M27164 | |
| Pathway | REACTOME_CROSSLINKING_OF_COLLAGEN_FIBRILS | 3.83e-04 | 18 | 23 | 2 | MM14882 | |
| Pathway | REACTOME_COLLAGEN_FORMATION | 4.06e-04 | 90 | 23 | 3 | M631 | |
| Pathway | BIOCARTA_AMI_PATHWAY | 4.75e-04 | 20 | 23 | 2 | M15394 | |
| Pathway | REACTOME_NCAM1_INTERACTIONS | 4.75e-04 | 20 | 23 | 2 | MM15061 | |
| Pathway | BIOCARTA_INTRINSIC_PATHWAY | 6.31e-04 | 23 | 23 | 2 | M15997 | |
| Pathway | BIOCARTA_INTRINSIC_PATHWAY | 6.31e-04 | 23 | 23 | 2 | MM1427 | |
| Pathway | REACTOME_ENDOGENOUS_STEROLS | 7.47e-04 | 25 | 23 | 2 | M11184 | |
| Pathway | REACTOME_ENDOGENOUS_STEROLS | 8.72e-04 | 27 | 23 | 2 | MM14844 | |
| Pathway | REACTOME_REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA | 8.96e-04 | 118 | 23 | 3 | M27316 | |
| Pathway | REACTOME_LAMININ_INTERACTIONS | 1.08e-03 | 30 | 23 | 2 | M27216 | |
| Pathway | REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS | 1.23e-03 | 32 | 23 | 2 | MM14924 | |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | 1.47e-03 | 140 | 23 | 3 | M587 | |
| Pathway | REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH | 1.73e-03 | 38 | 23 | 2 | MM14969 | |
| Pathway | REACTOME_NCAM1_INTERACTIONS | 2.11e-03 | 42 | 23 | 2 | M7169 | |
| Pathway | PID_INTEGRIN3_PATHWAY | 2.21e-03 | 43 | 23 | 2 | M53 | |
| Pathway | REACTOME_SUMOYLATION_OF_TRANSCRIPTION_COFACTORS | 2.31e-03 | 44 | 23 | 2 | M27295 | |
| Pathway | WP_NEPHROTIC_SYNDROME | 2.42e-03 | 45 | 23 | 2 | M39864 | |
| Pathway | REACTOME_ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES | 2.97e-03 | 50 | 23 | 2 | MM14796 | |
| Pathway | REACTOME_COLLAGEN_DEGRADATION | 3.34e-03 | 53 | 23 | 2 | MM14566 | |
| Pathway | REACTOME_SIGNALING_BY_PDGF | 3.85e-03 | 57 | 23 | 2 | MM14713 | |
| Pathway | REACTOME_SIGNALING_BY_PDGF | 3.98e-03 | 58 | 23 | 2 | M2049 | |
| Pathway | WP_CIRCADIAN_RHYTHM_GENES | 4.10e-03 | 201 | 23 | 3 | M39605 | |
| Pathway | REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS | 4.12e-03 | 59 | 23 | 2 | M27218 | |
| Pathway | REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH | 4.68e-03 | 63 | 23 | 2 | M11187 | |
| Pathway | PID_ERA_GENOMIC_PATHWAY | 4.83e-03 | 64 | 23 | 2 | M200 | |
| Pathway | REACTOME_CYTOCHROME_P450_ARRANGED_BY_SUBSTRATE_TYPE | 4.83e-03 | 64 | 23 | 2 | M5650 | |
| Pathway | REACTOME_CYTOCHROME_P450_ARRANGED_BY_SUBSTRATE_TYPE | 5.13e-03 | 66 | 23 | 2 | MM14839 | |
| Pathway | PID_INTEGRIN1_PATHWAY | 5.13e-03 | 66 | 23 | 2 | M18 | |
| Pathway | REACTOME_REGULATION_OF_PTEN_STABILITY_AND_ACTIVITY | 5.59e-03 | 69 | 23 | 2 | MM15540 | |
| Pathway | REACTOME_REGULATION_OF_PTEN_STABILITY_AND_ACTIVITY | 5.59e-03 | 69 | 23 | 2 | M27815 | |
| Pubmed | Comparative Application of BioID and TurboID for Protein-Proximity Biotinylation. | 8.57e-11 | 457 | 29 | 9 | 32344865 | |
| Pubmed | 1.63e-07 | 152 | 29 | 5 | 38360978 | ||
| Pubmed | 3.70e-07 | 347 | 29 | 6 | 16033648 | ||
| Pubmed | An inducible CRISPR/Cas9 screen identifies DTX2 as a transcriptional regulator of human telomerase. | 3.77e-07 | 180 | 29 | 5 | 35198878 | |
| Pubmed | COL4A3/COL4A4 mutations and features in individuals with autosomal recessive Alport syndrome. | 6.71e-07 | 2 | 29 | 2 | 24052634 | |
| Pubmed | 6.71e-07 | 2 | 29 | 2 | 19357112 | ||
| Pubmed | 6.71e-07 | 2 | 29 | 2 | 12768082 | ||
| Pubmed | 6.71e-07 | 2 | 29 | 2 | 25229338 | ||
| Pubmed | 6.71e-07 | 2 | 29 | 2 | 17942953 | ||
| Pubmed | Polymorphisms in COL4A3 and COL4A4 genes associated with keratoconus. | 6.71e-07 | 2 | 29 | 2 | 20029656 | |
| Pubmed | Mutation analysis of COL4A3 and COL4A4 genes in a Chinese autosomal-dominant Alport syndrome family. | 6.71e-07 | 2 | 29 | 2 | 28674241 | |
| Pubmed | Persistent familial hematuria in children and the locus for thin basement membrane nephropathy. | 6.71e-07 | 2 | 29 | 2 | 16235097 | |
| Pubmed | 6.71e-07 | 2 | 29 | 2 | 9537506 | ||
| Pubmed | 6.71e-07 | 2 | 29 | 2 | 25381091 | ||
| Pubmed | Collagen type IV (alpha3-alpha4) nephropathy: from isolated haematuria to renal failure. | 6.71e-07 | 2 | 29 | 2 | 15280517 | |
| Pubmed | 6.71e-07 | 2 | 29 | 2 | 7987396 | ||
| Pubmed | Heterozygous COL4A3/COL4A4 mutations: the hidden part of the iceberg? | 6.71e-07 | 2 | 29 | 2 | 35090027 | |
| Pubmed | 6.71e-07 | 2 | 29 | 2 | 15880327 | ||
| Pubmed | 6.71e-07 | 2 | 29 | 2 | 29742505 | ||
| Pubmed | 6.71e-07 | 2 | 29 | 2 | 38214412 | ||
| Pubmed | Nine novel COL4A3 and COL4A4 mutations and polymorphisms identified in inherited membrane diseases. | 6.71e-07 | 2 | 29 | 2 | 17216251 | |
| Pubmed | 6.71e-07 | 2 | 29 | 2 | 35369551 | ||
| Pubmed | Presumed COL4A3/COL4A4 Missense/Synonymous Variants Induce Aberrant Splicing. | 6.71e-07 | 2 | 29 | 2 | 35386907 | |
| Pubmed | COL4A3/COL4A4 mutations: from familial hematuria to autosomal-dominant or recessive Alport syndrome. | 6.71e-07 | 2 | 29 | 2 | 12028435 | |
| Pubmed | Polymorphism analysis of COL4A3 and COL4A4 genes in Greek patients with keratoconus. | 6.71e-07 | 2 | 29 | 2 | 25083577 | |
| Pubmed | 6.71e-07 | 2 | 29 | 2 | 20847057 | ||
| Pubmed | 6.71e-07 | 2 | 29 | 2 | 25307543 | ||
| Pubmed | 6.71e-07 | 2 | 29 | 2 | 18661361 | ||
| Pubmed | Genetic, Clinical, and Pathologic Backgrounds of Patients with Autosomal Dominant Alport Syndrome. | 6.71e-07 | 2 | 29 | 2 | 27281700 | |
| Pubmed | [From Alport syndrome to benign familial hematuria: clinical and genetic aspect]. | 6.71e-07 | 2 | 29 | 2 | 16895672 | |
| Pubmed | 6.71e-07 | 2 | 29 | 2 | 32232700 | ||
| Pubmed | ATAC and Mediator coactivators form a stable complex and regulate a set of non-coding RNA genes. | 1.90e-06 | 107 | 29 | 4 | 20508642 | |
| Pubmed | Collagen IV diseases: A focus on the glomerular basement membrane in Alport syndrome. | 2.01e-06 | 3 | 29 | 2 | 27576055 | |
| Pubmed | Novel COL4A5, COL4A4, and COL4A3 mutations in Alport syndrome. | 2.01e-06 | 3 | 29 | 2 | 15954103 | |
| Pubmed | 2.01e-06 | 3 | 29 | 2 | 36130833 | ||
| Pubmed | 2.01e-06 | 3 | 29 | 2 | 14507670 | ||
| Pubmed | Genetic diagnosis of Alport syndrome in 16 Chinese families. | 2.01e-06 | 3 | 29 | 2 | 38433557 | |
| Pubmed | Alport syndrome: impact of digenic inheritance in patients management. | 2.01e-06 | 3 | 29 | 2 | 27859054 | |
| Pubmed | 2.01e-06 | 3 | 29 | 2 | 25575550 | ||
| Pubmed | 2.01e-06 | 3 | 29 | 2 | 17396119 | ||
| Pubmed | A mouse Col4a4 mutation causing Alport glomerulosclerosis with abnormal collagen α3α4α5(IV) trimers. | 2.01e-06 | 3 | 29 | 2 | 24522496 | |
| Pubmed | 2.01e-06 | 3 | 29 | 2 | 3089234 | ||
| Pubmed | 2.01e-06 | 3 | 29 | 2 | 7962065 | ||
| Pubmed | Novel mutations in COL4A3, COL4A4, and COL4A5 in Chinese patients with Alport Syndrome. | 2.01e-06 | 3 | 29 | 2 | 28542346 | |
| Pubmed | 2.01e-06 | 3 | 29 | 2 | 28704582 | ||
| Pubmed | 2.01e-06 | 3 | 29 | 2 | 18930919 | ||
| Pubmed | Integration of Genetic Testing and Pathology for the Diagnosis of Adults with FSGS. | 2.01e-06 | 3 | 29 | 2 | 30647093 | |
| Pubmed | 2.01e-06 | 3 | 29 | 2 | 38978054 | ||
| Pubmed | 2.01e-06 | 3 | 29 | 2 | 24033287 | ||
| Pubmed | 2.01e-06 | 3 | 29 | 2 | 33654185 | ||
| Pubmed | 2.01e-06 | 3 | 29 | 2 | 14633121 | ||
| Pubmed | 2.01e-06 | 3 | 29 | 2 | 20301386 | ||
| Pubmed | 2.37e-06 | 1103 | 29 | 8 | 34189442 | ||
| Pubmed | 2.67e-06 | 268 | 29 | 5 | 33640491 | ||
| Pubmed | Nature and the multiple functions of the 67-kD elastin-/laminin binding protein. | 4.02e-06 | 4 | 29 | 2 | 7827955 | |
| Pubmed | 4.02e-06 | 4 | 29 | 2 | 20664914 | ||
| Pubmed | 6.70e-06 | 5 | 29 | 2 | 9409248 | ||
| Pubmed | 6.70e-06 | 5 | 29 | 2 | 12810069 | ||
| Pubmed | 7.85e-06 | 153 | 29 | 4 | 25037231 | ||
| Pubmed | Insertional mutation of the collagen genes Col4a3 and Col4a4 in a mouse model of Alport syndrome. | 1.00e-05 | 6 | 29 | 2 | 10534397 | |
| Pubmed | Stimulation of extracellular matrix components in the normal brain by invading glioma cells. | 1.00e-05 | 6 | 29 | 2 | 9506531 | |
| Pubmed | 1.00e-05 | 6 | 29 | 2 | 7495302 | ||
| Pubmed | A tumor derived motility factor that stimulates cell migration on extracellular matrix. | 1.00e-05 | 6 | 29 | 2 | 9673377 | |
| Pubmed | 1.00e-05 | 6 | 29 | 2 | 2426947 | ||
| Pubmed | Angiogenesis and collagen type IV expression in different endothelial cell culture systems. | 1.00e-05 | 6 | 29 | 2 | 23551189 | |
| Pubmed | Monoclonal antibody to human basement membrane collagen type IV. | 1.00e-05 | 6 | 29 | 2 | 6811420 | |
| Pubmed | 1.00e-05 | 6 | 29 | 2 | 11732842 | ||
| Pubmed | Developmental distribution of collagen IV isoforms and relevance to ocular diseases. | 1.00e-05 | 6 | 29 | 2 | 19275937 | |
| Pubmed | 1.00e-05 | 6 | 29 | 2 | 6988303 | ||
| Pubmed | Immunolocalization of collagen types, laminin and fibronectin in the normal human pancreas. | 1.00e-05 | 6 | 29 | 2 | 6389236 | |
| Pubmed | 1.00e-05 | 6 | 29 | 2 | 12225806 | ||
| Pubmed | 1.12e-05 | 963 | 29 | 7 | 28671696 | ||
| Pubmed | 1.41e-05 | 7 | 29 | 2 | 10639489 | ||
| Pubmed | 1.41e-05 | 7 | 29 | 2 | 7521231 | ||
| Pubmed | 1.41e-05 | 7 | 29 | 2 | 11711546 | ||
| Pubmed | Regulation of protease nexin-1 target protease specificity by collagen type IV. | 1.41e-05 | 7 | 29 | 2 | 8006028 | |
| Pubmed | 1.41e-05 | 7 | 29 | 2 | 10416788 | ||
| Pubmed | Hypoplastic basement membrane of the lens anlage in the inheritable lens aplastic mouse (lap mouse). | 1.41e-05 | 7 | 29 | 2 | 10716744 | |
| Pubmed | 1.41e-05 | 7 | 29 | 2 | 1724753 | ||
| Pubmed | 1.83e-05 | 399 | 29 | 5 | 35987950 | ||
| Pubmed | 1.87e-05 | 8 | 29 | 2 | 10382266 | ||
| Pubmed | 1.87e-05 | 8 | 29 | 2 | 11683410 | ||
| Pubmed | 1.87e-05 | 8 | 29 | 2 | 3997552 | ||
| Pubmed | Type IV collagen α6 chain is a regulator of keratin 10 in keratinization of oral mucosal epithelium. | 1.87e-05 | 8 | 29 | 2 | 29422532 | |
| Pubmed | 1.87e-05 | 8 | 29 | 2 | 1383086 | ||
| Pubmed | Molecular properties of wild-type and mutant betaIG-H3 proteins. | 1.87e-05 | 8 | 29 | 2 | 11867580 | |
| Pubmed | ATG5 is required for B cell polarization and presentation of particulate antigens. | 2.10e-05 | 701 | 29 | 6 | 30196744 | |
| Pubmed | Transcription factor protein interactomes reveal genetic determinants in heart disease. | 2.11e-05 | 411 | 29 | 5 | 35182466 | |
| Pubmed | 2.41e-05 | 9 | 29 | 2 | 9878537 | ||
| Pubmed | Analysis of candidate genes on chromosome 2 in oral cleft case-parent trios from three populations. | 2.41e-05 | 9 | 29 | 2 | 16953426 | |
| Pubmed | 2.41e-05 | 9 | 29 | 2 | 8562707 | ||
| Pubmed | 2.41e-05 | 9 | 29 | 2 | 12101409 | ||
| Pubmed | 2.41e-05 | 9 | 29 | 2 | 10880400 | ||
| Pubmed | Loss of the collagen IV modifier prolyl 3-hydroxylase 2 causes thin basement membrane nephropathy. | 2.41e-05 | 9 | 29 | 2 | 35499085 | |
| Pubmed | 2.41e-05 | 9 | 29 | 2 | 8995276 | ||
| Pubmed | 2.48e-05 | 425 | 29 | 5 | 24999758 | ||
| Pubmed | 2.53e-05 | 206 | 29 | 4 | 22174317 | ||
| Pubmed | 2.93e-05 | 214 | 29 | 4 | 22199357 | ||
| Pubmed | 3.01e-05 | 10 | 29 | 2 | 9136074 | ||
| Pubmed | 3.01e-05 | 10 | 29 | 2 | 9415455 | ||
| Interaction | NUP35 interactions | 5.12e-09 | 424 | 29 | 9 | int:NUP35 | |
| Interaction | DTX2 interactions | 6.37e-06 | 330 | 29 | 6 | int:DTX2 | |
| Interaction | AR interactions | 6.71e-06 | 992 | 29 | 9 | int:AR | |
| Interaction | TADA2A interactions | 8.53e-06 | 198 | 29 | 5 | int:TADA2A | |
| Interaction | EYA4 interactions | 2.29e-05 | 243 | 29 | 5 | int:EYA4 | |
| Interaction | PAX9 interactions | 3.46e-05 | 130 | 29 | 4 | int:PAX9 | |
| Interaction | CEBPA interactions | 4.13e-05 | 1245 | 29 | 9 | int:CEBPA | |
| Interaction | HNRNPM interactions | 5.81e-05 | 723 | 29 | 7 | int:HNRNPM | |
| Interaction | SAA1 interactions | 6.32e-05 | 54 | 29 | 3 | int:SAA1 | |
| Interaction | MTDH interactions | 6.99e-05 | 505 | 29 | 6 | int:MTDH | |
| Interaction | SAFB2 interactions | 1.67e-04 | 195 | 29 | 4 | int:SAFB2 | |
| Interaction | CEACAM5 interactions | 1.80e-04 | 14 | 29 | 2 | int:CEACAM5 | |
| Interaction | SOX7 interactions | 2.20e-04 | 82 | 29 | 3 | int:SOX7 | |
| Interaction | EWSR1 interactions | 2.37e-04 | 906 | 29 | 7 | int:EWSR1 | |
| Interaction | HNRNPD interactions | 2.51e-04 | 638 | 29 | 6 | int:HNRNPD | |
| Interaction | GATA4 interactions | 2.73e-04 | 411 | 29 | 5 | int:GATA4 | |
| Cytoband | 19p13.3-p13.2 | 3.49e-05 | 14 | 29 | 2 | 19p13.3-p13.2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr2q36 | 1.33e-03 | 85 | 29 | 2 | chr2q36 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr13q12 | 9.59e-03 | 234 | 29 | 2 | chr13q12 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr20q11 | 1.07e-02 | 248 | 29 | 2 | chr20q11 | |
| GeneFamily | RNA binding motif containing | 1.17e-07 | 213 | 21 | 6 | 725 | |
| GeneFamily | Collagens | 1.99e-05 | 46 | 21 | 3 | 490 | |
| GeneFamily | Basic helix-loop-helix proteins | 7.14e-03 | 110 | 21 | 2 | 420 | |
| Coexpression | NABA_BASEMENT_MEMBRANES | 1.17e-05 | 40 | 29 | 3 | M5887 | |
| Coexpression | NABA_COLLAGENS | 1.46e-05 | 43 | 29 | 3 | MM17060 | |
| Coexpression | NABA_COLLAGENS | 1.56e-05 | 44 | 29 | 3 | M3005 | |
| Coexpression | GSE22886_UNSTIM_VS_IL2_STIM_NKCELL_UP | 6.22e-05 | 196 | 29 | 4 | M4530 | |
| ToppCell | severe_influenza-B_memory|World / disease group, cell group and cell class (v2) | 4.55e-06 | 172 | 29 | 4 | 0ff38f9431cec73250c580a6010cb7891a3fe3f1 | |
| ToppCell | PBMC-Mild-Lymphocyte-B-B_cell-B_memory-B_memory-0|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.74e-06 | 190 | 29 | 4 | 95b9334573eefb132daaa9371377ad60232006ae | |
| ToppCell | mild_COVID-19-B_memory|World / disease group, cell group and cell class (v2) | 7.17e-06 | 193 | 29 | 4 | 69b70c838328fdc7dbb6b5449fe2811a5389a839 | |
| ToppCell | mild_COVID-19-B_memory|mild_COVID-19 / disease group, cell group and cell class (v2) | 7.17e-06 | 193 | 29 | 4 | 7e6fe70928a50b0a8f12220e572c07c5670d092e | |
| ToppCell | severe_COVID-19-B_memory|severe_COVID-19 / disease group, cell group and cell class (v2) | 7.62e-06 | 196 | 29 | 4 | c6e00cb59a88b9903cca233cefe05f80c5ea4153 | |
| ToppCell | COVID-19-COVID-19_Mild-Lymphocyte-B-B_memory|COVID-19_Mild / Disease, condition lineage and cell class | 8.09e-06 | 199 | 29 | 4 | 54e392b4ebe601d4838739ff7de3ac6b2203c948 | |
| ToppCell | 368C-Myeloid-Monocyte-CD16+_Monocyte|368C / Donor, Lineage, Cell class and subclass (all cells) | 1.40e-04 | 156 | 29 | 3 | 25b0936960be4955b6a6d6b8a867fdd4be548f05 | |
| ToppCell | PBMC-Mild-Myeloid-cDC-cDC-cDC_6|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.48e-04 | 159 | 29 | 3 | 6115cb03c2ad08e4c1b65893d522f685ff0bc692 | |
| ToppCell | PBMC-Mild-Myeloid-cDC-cDC-cDC_6|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.51e-04 | 160 | 29 | 3 | a90eb621481fd07a821495db07d1032e109fd386 | |
| ToppCell | AT1_cells-IPF_01|World / lung cells shred on cell class, cell subclass, sample id | 1.56e-04 | 162 | 29 | 3 | ae2ba4f21f6f6c512006fa531d670b88be7c04c9 | |
| ToppCell | AT1-AT2_cells-IPF_01|World / lung cells shred on cell class, cell subclass, sample id | 1.56e-04 | 162 | 29 | 3 | 57d627259d27f39885bf416d74bcb6656db6e27b | |
| ToppCell | Influenza_Severe-B_memory|Influenza_Severe / Disease group and Cell class | 1.65e-04 | 165 | 29 | 3 | 51172acaeb667b34b8b8c7878d67cfa0c4a2dffc | |
| ToppCell | P15-Epithelial-airway_epithelial_cell-ciliated_cell_of_airway|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.71e-04 | 167 | 29 | 3 | 5c3d0763f73628c71c71f9883556bb4f1639f3cc | |
| ToppCell | facs-Marrow-B-cells-18m-Myeloid-monocyte_+_promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.80e-04 | 170 | 29 | 3 | 18cd941bf3ca7cc0b6af1317bd2619d283353de0 | |
| ToppCell | healthy_donor-Myeloid-Monocytic-Developing_Neutrophil|healthy_donor / Disease condition, Lineage, Cell class and subclass | 1.80e-04 | 170 | 29 | 3 | cfd7f29805b7c51666b0eaf269c36c96b8765a1a | |
| ToppCell | facs-Marrow-B-cells-18m-Myeloid-promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.80e-04 | 170 | 29 | 3 | 6e82e41acd1299aa549a32ac036b39754abdf376 | |
| ToppCell | AT1-AT2_cells-Donor_06|World / lung cells shred on cell class, cell subclass, sample id | 1.96e-04 | 175 | 29 | 3 | bdd85ba280648a0283c1984662a34c7b840f64dd | |
| ToppCell | PND14-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1/AT2-AT1/AT2_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.96e-04 | 175 | 29 | 3 | cb974fbebe8cb58c7d3f7defabb4e056f2fee5fa | |
| ToppCell | AT1-AT2_cells-HP_01|World / lung cells shred on cell class, cell subclass, sample id | 1.96e-04 | 175 | 29 | 3 | 9a95ab5c361ebaa8747983c5a0d69025682a19ad | |
| ToppCell | E18.5-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1-AT1_prolif|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.96e-04 | 175 | 29 | 3 | 711ace94fa9a763c6ae48171a690953f25deebe4 | |
| ToppCell | PND14-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1/AT2|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.96e-04 | 175 | 29 | 3 | 96219e58dcb327fd27190be78193e7a0d611e62b | |
| ToppCell | droplet-Liver-LIVER-30m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.00e-04 | 176 | 29 | 3 | 4880fa20b50eb10358e08567e08559ef2954f237 | |
| ToppCell | droplet-Liver-LIVER-30m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.00e-04 | 176 | 29 | 3 | fcdddd949ca05b3ecde240db9e38296a6eab2d6a | |
| ToppCell | droplet-Liver-LIVER-30m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.00e-04 | 176 | 29 | 3 | 4d2fb51e71bed0d72f3d7f89d395744860885a5f | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Neuronal-Glial_immature-Glia_3_(BCAN+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.03e-04 | 177 | 29 | 3 | d05497d2c80a66ec6a4e1733fea3a5534877a6a7 | |
| ToppCell | COVID-19_Moderate-B_memory|World / disease group, cell group and cell class | 2.13e-04 | 180 | 29 | 3 | 2f37187b866edb56410c2334b72713f2248dc335 | |
| ToppCell | facs-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l17|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.13e-04 | 180 | 29 | 3 | 39ae8586efd91536e9ac6408d26de7e6d6237c41 | |
| ToppCell | 10x5'v1-week_14-16-Lymphocytic_NK-T_NK-ILC_precursor|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.13e-04 | 180 | 29 | 3 | a999a6d219a8e58a8b63802ddf8c95ffaab9cfa0 | |
| ToppCell | severe_influenza-B_memory|severe_influenza / disease group, cell group and cell class (v2) | 2.17e-04 | 181 | 29 | 3 | 92e572c92109a6dae0f73138c57c3bbd2e0a2f36 | |
| ToppCell | normal-na-Lymphocytic_B-B_mem-male|normal / PBMC cell types (v2) per disease, treatment status, and sex | 2.20e-04 | 182 | 29 | 3 | ee36ea6cb9a5a08aeb83f2b7a249255f0b1a9870 | |
| ToppCell | COVID-19_Moderate-B_memory|COVID-19_Moderate / disease group, cell group and cell class | 2.20e-04 | 182 | 29 | 3 | bbdbef62389ac062118cc0c7979686393399f2c8 | |
| ToppCell | 5'-GW_trimst-2-LymphNode-Hematopoietic-T_cells-ILCP|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.24e-04 | 183 | 29 | 3 | 4a1e5bf58d2acd9dbceeef538b6851c1e5e91059 | |
| ToppCell | Control-Lymphocyte-B-B_memory|Control / Disease, Lineage and Cell Type | 2.24e-04 | 183 | 29 | 3 | 491fa04a1d2caeeec6c6403c9a38b4a1257fc2bc | |
| ToppCell | Healthy/Control-B_memory|World / Disease group and Cell class | 2.27e-04 | 184 | 29 | 3 | 9e1879d86b535ede9b47deb0752e291f987a5d5e | |
| ToppCell | droplet-Liver-Hepatocytes-24m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.35e-04 | 186 | 29 | 3 | 2cae34336f184f971f7c8684cc27c23a4e7369ed | |
| ToppCell | droplet-Liver-Hepatocytes-24m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.35e-04 | 186 | 29 | 3 | 90d53c2597a9f3a2b39afba75adfc54f1ca0a4db | |
| ToppCell | COVID-19_Severe-B_memory|World / disease group, cell group and cell class | 2.38e-04 | 187 | 29 | 3 | f29c71f2505bb64f3010ada491d422b87a6f7db3 | |
| ToppCell | droplet-Lung-1m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l17|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.38e-04 | 187 | 29 | 3 | ed7ab4cf4629d96dad5c74d536fc428d0a8d4eb9 | |
| ToppCell | Healthy_donor-B_memory|World / disease group, cell group and cell class (v2) | 2.38e-04 | 187 | 29 | 3 | 4f68e3243071a4549c80aff8bff32c6ad892ee7f | |
| ToppCell | LA-01._Fibroblast_I|World / Chamber and Cluster_Paper | 2.38e-04 | 187 | 29 | 3 | 4ea486991f66c29728d127171a07b81404ec0b78 | |
| ToppCell | PBMC-Mild-Lymphocyte-B-B_cell-B_memory-B_memory-3|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.42e-04 | 188 | 29 | 3 | cd833a125a5279ac32a9a9cb9ecd05ae24bea3a9 | |
| ToppCell | Control-Lymphoid_B-B_memory|Control / Disease group, lineage and cell class | 2.42e-04 | 188 | 29 | 3 | ba4245de3bee29118abab57c4fce60b2007a189c | |
| ToppCell | COVID-19-kidney-DCT|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.42e-04 | 188 | 29 | 3 | 1d56cd409793f05cca20757ab26e91f1a1ee67b5 | |
| ToppCell | AT1-AT2_cells-Donor_01|World / lung cells shred on cell class, cell subclass, sample id | 2.42e-04 | 188 | 29 | 3 | be710bc957118cf426dd71c2d57e6f1b41c9a467 | |
| ToppCell | Healthy/Control-B_memory|Healthy/Control / Disease group and Cell class | 2.42e-04 | 188 | 29 | 3 | 3aff07f77b2b15e7a30e47b30115178abe64474e | |
| ToppCell | PBMC-Control-Lymphocyte-B-B_cell-B_memory|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.42e-04 | 188 | 29 | 3 | 9256c5f45c97df209bb9c322c3b557d4f726a333 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_B-B_cell-B_c02-MS4A1-CD27|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.42e-04 | 188 | 29 | 3 | 5707786cc4452dc34f95db2b3cd29f6e025c0622 | |
| ToppCell | PBMC-Severe-Lymphocyte-B-B_cell-B_memory-B_memory-0|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.42e-04 | 188 | 29 | 3 | 229108e7e3db49e1cfd747d69e338394139d95b3 | |
| ToppCell | PBMC-Control-Lymphocyte-B-B_cell-B_memory-B_memory-0|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.42e-04 | 188 | 29 | 3 | 6f53bcd4caab2fc961af799039ea5c3ddae56781 | |
| ToppCell | COVID-19-kidney-DCT|kidney / Disease (COVID-19 only), tissue and cell type | 2.42e-04 | 188 | 29 | 3 | df1fd0819d301679f3c9ea404e942e39095912eb | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.46e-04 | 189 | 29 | 3 | 55420853f730b433ef58ac9337ac84ac78a247a0 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.46e-04 | 189 | 29 | 3 | 7eb8f5a951e80f1cfac4d7c9eb169f4eb100c917 | |
| ToppCell | PBMC-Control-Lymphocyte-B-B_cell-B_memory-B_memory-3|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.46e-04 | 189 | 29 | 3 | ac0203f17b481d608587113ea2de0f383b29ed27 | |
| ToppCell | droplet-Liver-Hepatocytes-24m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.46e-04 | 189 | 29 | 3 | ce5b3d53c9a5457a5a02b221dee18334b5eaf8b7 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.46e-04 | 189 | 29 | 3 | 975c0f079903ae36b0ffa54e86294d42ec7697de | |
| ToppCell | Healthy_donor-B_memory|Healthy_donor / disease group, cell group and cell class (v2) | 2.50e-04 | 190 | 29 | 3 | 46104a521f00d399315deca86699cb261b2795d6 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_B-B_cell-B_c03-CD27-AIM2|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.50e-04 | 190 | 29 | 3 | 0db545a4cba7534bad2693e0d565cde7dbc7a586 | |
| ToppCell | COVID-19_Severe-Lymphoid_B-B_memory|COVID-19_Severe / Disease group, lineage and cell class | 2.50e-04 | 190 | 29 | 3 | b6510c419a15ed049c0a0a6a6697b643668741c3 | |
| ToppCell | Severe-MAIT|World / Disease group and Cell class | 2.50e-04 | 190 | 29 | 3 | 7a92e0d6a021be23125495927b8571e25c83204a | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_B-Memory_B_cells|bone_marrow / Manually curated celltypes from each tissue | 2.54e-04 | 191 | 29 | 3 | 67479df0ca4c5a792fd604aded3f75609fec0888 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.54e-04 | 191 | 29 | 3 | 39092a0aff8097617820c59f5fea9ee2bb4f63a2 | |
| ToppCell | Control-Lymphoid_B|Control / Disease group, lineage and cell class | 2.54e-04 | 191 | 29 | 3 | 0a760cd3a48c487ec899adb882fddea8914cfe0c | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Cortical_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.54e-04 | 191 | 29 | 3 | 963f4f2e852bbb4faf070aafb0d368297abacd3b | |
| ToppCell | PBMC-Mild-Lymphocyte-B-B_cell-B_intermediate-B_intermediate-0|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.54e-04 | 191 | 29 | 3 | 5a9a592875fbd0b1429b48db29a760fdc9c2c856 | |
| ToppCell | Control-Lymphoid_B-B_intermediate|Control / Disease group, lineage and cell class | 2.54e-04 | 191 | 29 | 3 | 0082181dbc39c7c4fd3aa34c3ed61439548e844b | |
| ToppCell | PBMC-Control-Lymphocyte-B-B_cell-B_memory|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.54e-04 | 191 | 29 | 3 | 03f6da73e7b706252d2096507222229c4101a27b | |
| ToppCell | COVID-19-kidney-Mito-rich_Distal|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.54e-04 | 191 | 29 | 3 | 0965f621ebcd92ccdeb21cc27022180ce3cfe910 | |
| ToppCell | COVID-19-kidney-TAL|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.54e-04 | 191 | 29 | 3 | fe55475ce0666ab5122447a813dc2369e24947b8 | |
| ToppCell | PBMC-Control-Lymphocyte-B-B_cell-B_memory-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.54e-04 | 191 | 29 | 3 | 578b58782e816ecaeabfbc616ceb1dcd53ee428b | |
| ToppCell | B_cells|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 2.54e-04 | 191 | 29 | 3 | 72e3191990973440e4f91427208df360f73e4f41 | |
| ToppCell | severe_COVID-19-B_memory|World / disease group, cell group and cell class (v2) | 2.54e-04 | 191 | 29 | 3 | 3b57e353b74ebc866d0e11deeba31fa764c42325 | |
| ToppCell | PBMC-Mild-Lymphocyte-B-B_cell-B_memory|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.54e-04 | 191 | 29 | 3 | 22134a2c1a92208bc1629a620ce73a56502613c2 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.54e-04 | 191 | 29 | 3 | ee5f1b1c59029c46cbb1a00935c03b9317bb9da9 | |
| ToppCell | PBMC-Mild-Lymphocyte-B-B_cell-B_memory|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.58e-04 | 192 | 29 | 3 | 314f74dd3c6d94839eed05b9a1a398217ef78029 | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.58e-04 | 192 | 29 | 3 | 840a34c1b82d218be999ab5e1bcafd6370d7a4b1 | |
| ToppCell | PBMC-Mild-Lymphocyte-B-B_cell-B_memory-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.58e-04 | 192 | 29 | 3 | debd471f61cf3606b8e9c246add0be5df601af7f | |
| ToppCell | control-B_memory|control / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.58e-04 | 192 | 29 | 3 | d6ef271b6c4f9b49323650f3f773abd61c1b13c3 | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic_B-B_mem-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 2.58e-04 | 192 | 29 | 3 | 80a71ab3434076803466ccac0df73468889c7dd3 | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-lymphocytic-B_lymphocytic-B_cell|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.58e-04 | 192 | 29 | 3 | 0bda96d8f223e8fa9caf935079ab202fc5c812ee | |
| ToppCell | PBMC-Severe-Lymphocyte-B-B_cell-B_memory-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.58e-04 | 192 | 29 | 3 | dac61f0b374f6f9476eedce97f341f26c1bc037c | |
| ToppCell | PBMC-Control-Lymphocyte-B-B_cell-B_intermediate-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.58e-04 | 192 | 29 | 3 | f9f64ad7bab1433e9a45adb7db7f43ce3f591b47 | |
| ToppCell | COVID-19-Heart-Fib_+_EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 2.58e-04 | 192 | 29 | 3 | 60b1312e84f6d6448365a952469c506c00b5fe93 | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.58e-04 | 192 | 29 | 3 | 671d4e1eee5aba03c43dbc98f4b51ce42b3df5d5 | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic_B-B_mem|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 2.58e-04 | 192 | 29 | 3 | 75ce635d669ff77d1fd54e10467f21d5e5d67b08 | |
| ToppCell | B_cells-Memory_B_cells|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 2.58e-04 | 192 | 29 | 3 | eef591095921ede098f41a2b81897b18915bb753 | |
| ToppCell | PBMC-Control-Lymphocyte-B-B_cell-B_intermediate-B_intermediate-0|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.58e-04 | 192 | 29 | 3 | 89b8ebdc285ed3c0f807fd1157271130d37dfa41 | |
| ToppCell | PBMC-Severe-Lymphocyte-B-B_cell-B_memory|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.58e-04 | 192 | 29 | 3 | 72f936f03bb9b58c1ccaaf8270c07f5bbf2ac355 | |
| ToppCell | PBMC-Control-Lymphocyte-B-B_cell-B_intermediate|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.58e-04 | 192 | 29 | 3 | 4884fd8ffa6fd6c30d7ac6bf447456b3397eabc5 | |
| ToppCell | COVID-19_Mild-Lymphoid_B-B_memory|COVID-19_Mild / Disease group, lineage and cell class | 2.58e-04 | 192 | 29 | 3 | d27db7669de95bddbea8ccb83e6f10ae7240b1ab | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_B-B_cell-B_c02-MS4A1-CD27|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.62e-04 | 193 | 29 | 3 | bbea475d2c4c7b29674ff302529f8f83dd666dcb | |
| ToppCell | PBMC-Mild-Lymphocyte-B-B_cell-B_intermediate|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.62e-04 | 193 | 29 | 3 | 7cc10e8b51091869d46e462f3214999e7b5348b1 | |
| ToppCell | B_cells-Activate_B_cells|World / Immune cells in Kidney/Urine in Lupus Nephritis | 2.62e-04 | 193 | 29 | 3 | b6da81920cf2e55f87ec8d4b2b5530cbf7ba2155 | |
| ToppCell | PBMC-Control-Lymphocyte-B-B_cell-B_intermediate|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.62e-04 | 193 | 29 | 3 | 8f1d6024ef092923321e6efd441b8d476db70aed | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_B-B_cell-B_c03-CD27-AIM2|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.62e-04 | 193 | 29 | 3 | 9f798a1bbd9f076c3122d02ed28418c18bb7a369 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_B-B_cell-B_c02-MS4A1-CD27|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.66e-04 | 194 | 29 | 3 | 5cd72330c9d9bb21b6c9d5d35085eade101486d1 | |
| ToppCell | PBMC-Mild-Lymphocyte-B-B_cell-B_intermediate|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.66e-04 | 194 | 29 | 3 | 2b61023a602d336ed0de174e9141046173db34e6 | |
| ToppCell | PBMC-Control-Lymphocyte-B|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.66e-04 | 194 | 29 | 3 | 39121c7d537ac103f6959271d814fd327be7114f | |
| ToppCell | PBMC-Mild-Lymphocyte-B-B_cell-B_intermediate-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.66e-04 | 194 | 29 | 3 | f2486b19ac52a48d19f80b38a5536bee3dad745b | |
| ToppCell | LA-02._Fibroblast_II|LA / Chamber and Cluster_Paper | 2.66e-04 | 194 | 29 | 3 | 234d1494c114cce77c619708bbcd8d5ce805f19b | |
| ToppCell | PBMC-Control-Lymphocyte-B-B_cell|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.66e-04 | 194 | 29 | 3 | 60542304899b99caa38e4abf6b71ba986fa6c399 | |
| Disease | ALPORT SYNDROME 2, AUTOSOMAL RECESSIVE | 8.68e-07 | 2 | 28 | 2 | C4746745 | |
| Disease | benign familial hematuria (is_implicated_in) | 8.68e-07 | 2 | 28 | 2 | DOID:0111365 (is_implicated_in) | |
| Disease | autosomal recessive Alport syndrome (is_implicated_in) | 8.68e-07 | 2 | 28 | 2 | DOID:0110033 (is_implicated_in) | |
| Disease | Alport syndrome, recessive type | 8.68e-07 | 2 | 28 | 2 | C2931254 | |
| Disease | Alport syndrome, dominant type | 8.68e-07 | 2 | 28 | 2 | C2931253 | |
| Disease | Thin basement membrane disease | 8.68e-07 | 2 | 28 | 2 | C0403440 | |
| Disease | Benign familial hematuria | 8.68e-07 | 2 | 28 | 2 | cv:C0241908 | |
| Disease | Alport syndrome | 2.60e-06 | 3 | 28 | 2 | cv:C1567741 | |
| Disease | autosomal recessive Alport syndrome (implicated_via_orthology) | 2.60e-06 | 3 | 28 | 2 | DOID:0110033 (implicated_via_orthology) | |
| Disease | Collagen IV-related nephropathies | 2.60e-06 | 3 | 28 | 2 | cv:CN076135 | |
| Disease | Hematuria, Benign Familial | 5.20e-06 | 4 | 28 | 2 | C0241908 | |
| Disease | Alport Syndrome | 5.20e-06 | 4 | 28 | 2 | C1567741 | |
| Disease | Alport Syndrome, X-Linked | 8.67e-06 | 5 | 28 | 2 | C1567742 | |
| Disease | Alport Syndrome, Autosomal Dominant | 8.67e-06 | 5 | 28 | 2 | C1567743 | |
| Disease | Alport Syndrome, Autosomal Recessive | 8.67e-06 | 5 | 28 | 2 | C1567744 | |
| Disease | hypertensive nephropathy | 1.30e-05 | 6 | 28 | 2 | C0848548 | |
| Disease | collagen disease (implicated_via_orthology) | 5.70e-05 | 12 | 28 | 2 | DOID:854 (implicated_via_orthology) | |
| Disease | basophil percentage of granulocytes | 6.68e-05 | 83 | 28 | 3 | EFO_0007995 | |
| Disease | albuminuria | 9.68e-05 | 94 | 28 | 3 | EFO_0004285 | |
| Disease | Renal glomerular disease | 2.17e-04 | 23 | 28 | 2 | C0268731 | |
| Disease | Glomerulopathy Assessment | 2.17e-04 | 23 | 28 | 2 | C4521256 | |
| Disease | Kallmann Syndrome | 2.78e-04 | 26 | 28 | 2 | C0162809 | |
| Disease | colorectal carcinoma (is_marker_for) | 5.67e-04 | 37 | 28 | 2 | DOID:0080199 (is_marker_for) | |
| Disease | end stage renal disease (is_implicated_in) | 6.96e-04 | 41 | 28 | 2 | DOID:783 (is_implicated_in) | |
| Disease | myopathy (implicated_via_orthology) | 9.53e-04 | 48 | 28 | 2 | DOID:423 (implicated_via_orthology) | |
| Disease | basophil percentage of leukocytes | 1.55e-03 | 243 | 28 | 3 | EFO_0007992 | |
| Disease | R-warfarin measurement | 1.99e-03 | 265 | 28 | 3 | EFO_0803324 | |
| Disease | age at menopause | 2.88e-03 | 302 | 28 | 3 | EFO_0004704 | |
| Disease | refractive error | 3.57e-03 | 326 | 28 | 3 | MONDO_0004892 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| MEGPMGQRGREGPMG | 616 | Q9UMD9 | |
| MNSMRGGLPPREGRG | 451 | Q01844 | |
| RGIPGSMGNMGMPGS | 1011 | Q01955 | |
| MGAGGRRMRGAPARL | 1 | Q96PE1 | |
| GMRGPEGAMGLPGMR | 1386 | P53420 | |
| GAMGIGQRNMGPRNM | 441 | Q9P2D1 | |
| AGAMPARGGKRRSGM | 36 | Q9HBZ2 | |
| GVAGPMGRGRLMPNK | 1071 | Q96EV2 | |
| LGMMGLPGSRGPMGS | 161 | Q9Y215 | |
| GKGRPGIIRGMDMGA | 531 | Q07954 | |
| MGAGMGFGLERMAAP | 486 | P52272 | |
| RMVPAGMGAGLERMG | 531 | P52272 | |
| GMGAGLERMGPVMDR | 536 | P52272 | |
| LRAPAGRGRAMGGMP | 126 | Q8NBC4 | |
| GRGRAMGGMPRMGTV | 131 | Q8NBC4 | |
| MGGMPRMGTVGDFGQ | 136 | Q8NBC4 | |
| GGMGSLGAMGQPMSL | 111 | Q96RN5 | |
| MLRSMGGGQRPMGLG | 136 | P0CG42 | |
| TMGIMLGRMGDSGAP | 231 | O00341 | |
| MQRPLGMAGSGMGQS | 691 | Q86UU0 | |
| MLPMGIGDRGVMCGL | 71 | Q9UKN5 | |
| MDRLLRLGGGMPGLG | 1 | O00487 | |
| MDRGFLSGPMGSGMR | 501 | Q9P2K5 | |
| GMRGRELMGGIGKTM | 46 | P60602 | |
| SIVGCPRQQGMMGGM | 696 | P0CG39 | |
| MPMWAGGVGSPRRGM | 1 | Q96FS4 | |
| GPGHMMNRGGMSGRG | 861 | Q15424 | |
| KEQMGMPMGRFGGSG | 431 | Q15596 | |
| MPMGRFGGSGGMNHV | 436 | Q15596 | |
| GGGREPMLMVEGMLQ | 671 | Q99797 | |
| MRMGDMGPRGAINMG | 391 | Q8WXF1 | |
| GLVLGAMMERMGGFG | 211 | Q9UJA5 | |
| MQRRGALFGMPGGSG | 1 | Q92995 | |
| MGPMWRMRGGATRRG | 1 | Q2TAM9 |